Relation of peripheral neuropathy to HIV treatment in four randomized clinical trials including didanosine
- 31 July 1999
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 21 (7) , 1182-1192
- https://doi.org/10.1016/s0149-2918(00)80021-1
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic MillimeterNew England Journal of Medicine, 1996
- Zidovudine compared with didanosine in patients with advanced HIV type 1 infection and little or no previous experience with zidovudine. AIDS Clinical Trials GroupArchives of internal medicine (1960), 1995
- Rates and Risk Factors for Adverse Events Associated with Didanosine in the Expanded Access ProgramClinical Infectious Diseases, 1994
- Didanosine Compared with Continuation of Zidovudine in HIV-infected Patients with Signs of Clinical Deterioration While Receiving ZidovudineAnnals of Internal Medicine, 1994
- The Didanosine Expanded Access Program: Safety AnalysisClinical Infectious Diseases, 1993
- A Controlled Trial Comparing Continued Zidovudine with Didanosine in Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1992
- Peripheral neuropathy in the acquired immunodeficiency syndromeAnnals of Neurology, 1988
- Isolation of HTLV-III from Cerebrospinal Fluid and Neural Tissues of Patients with Neurologic Syndromes Related to the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1985